Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 14, 2025
New insights into thiopurine toxicity: The contribution of rare XDH variants to myelotoxicityHugo Tejera-Pérez, Alejandro Velasco-Ruiz, María Chaparro, et al.Nature Genetics|August 17, 2023
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer riskNaomi Wilcox, Martine Dumont, Anna González-Neira, et al.Journal of the National Cancer Institute|August 23, 2015
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian RandomizationBen Zhang, Xiao-Ou Shu, Ryan J Delahanty, et al.American Journal of Human Genetics|December 23, 2014
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1Dylan M Glubb, Mel J Maranian, Kyriaki Michailidou, et al.Human Molecular Genetics|February 6, 2015
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2Nick Orr, Frank Dudbridge, Nicola Dryden, et al.Nature Communications|April 11, 2018
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulationMaya Ghoussaini, Stacey L Edwards, Kyriaki Michailidou, et al.Journal of the National Cancer Institute|April 10, 2015
Prediction of breast cancer risk based on profiling with common genetic variantsNasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, et al.The New England Journal of Medicine|January 20, 2021
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women, Leila Dorling, Sara Carvalho, et al.Nature Genetics|March 10, 2015
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerKyriaki Michailidou, Jonathan Beesley, Sara Lindstrom, et al.Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.Pageof 4